Yi-ming Li

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer.

Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer.

Journal: Cell death discovery

Published: September 11, 2023

Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.

Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.

Journal: Frontiers in immunology

Published: June 26, 2021

Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer.

Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: August 06, 2019

Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.

Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.

Journal: Hepatology (Baltimore, Md.)

Published: January 02, 2019

RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.

RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.

Journal: Theranostics

Published: December 09, 2018

Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.

Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.

Journal: International journal of molecular sciences

Published: November 24, 2018

Postoperative adjuvant chemo (embolization) therapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Postoperative adjuvant chemo (embolization) therapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Journal: OncoTargets and therapy

Published: September 15, 2018

Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension.

Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension.

Journal: World journal of gastroenterology

Published: August 08, 2018

Association between KIF1B (rs17401966) polymorphism and hepatocellular carcinoma susceptibility: a meta-analysis.

Association between KIF1B (rs17401966) polymorphism and hepatocellular carcinoma susceptibility: a meta-analysis.

Journal: OncoTargets and therapy

Published: June 09, 2018

Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension.

Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension.

Journal: World journal of clinical cases

Published: April 05, 2018

miR‑494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN.

miR‑494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN.

Journal: International journal of oncology

Published: July 04, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026